USX:NERV - Minerva Neurosciences, Inc Minerva Neurosciences, Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 2 Aug 2021
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 2.48    +0.020 (+0.81%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

24 Jun 2021


Loading...
Loading...
Loading...

General

CEO: Dr. Remy Luthringer Ph.D.

IPO: 2014-07-01

Headquarters: US

Employees: 11

Homepage

Description

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It primarily focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301.